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Contact and Noncontact Mapping Systems 
in the Electrophysiology Laboratory
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A b s t r A c t
The most important step for the operator to perform a successful radiofrequency ab-
lation procedure for the treatment of cardiac tachyarrhythmias is to accurately iden-
tify the origin of and localize the arrhythmia focus and to determine the sequence of 
electrical activity. Intracardiac mapping techniques came a long distance from single 
catheter recordings to three dimensional voltage and morphology reconstructing sys-
tems. The aim of this review is to summarize the benefits and disadvantages of the 
existing cardiac mapping systems.
I N t r O D U c t I O N
The most important step for the operator to perform a successful radiofrequency 
ablation procedure for the treatment of cardiac tachyarrhythmias is to accurately identify 
the origin of and localize the arrhythmia focus and to determine the sequence of elec-
trical activity. Electrophysiology mapping, which started more than 40 years ago with 
single-channel recordings with a single catheter, has been transformed into a system 
in which multiple channels and multiple catheters are employed to make synchronous 
recordings possible in various anatomical regions of the heart and therefore can now 
provide more detailed information. Despite the synchronous recording, the fact that 
anatomical regions cannot be clearly distinguished in the two-dimensional fluoroscopic 
imaging has made the transition obligatory to systems in which the recordings combined 
together with the computer program and the activation sequence of the heart are 
given accurately along with three-dimensional mapping.1 Furthermore, although the 
use of a large number of endocardial catheters is beneficial in diagnosis and treatment 
of many tachyarrhythmias, the regions that recordings are taken and neighborhoods 
of ablation target points may not be clearly localized visually in various fluoroscopic 
projections. As the use of fluoroscopy in complex tachyarrhythmias is extended, and 
exposure to ionizing radiation is prolonged, dire need has emerged to develop differ-
ent mapping systems to facilitate these procedures.2 Among these mapping systems, 
the multi-electrode basket catheter and electromagnetic mapping systems (CARTO), 
as well as the traditional endocardial catheter mapping and electroanatomic mapping 
systems (NavX) (developed from a different version of the initially called Localisa sys-
tem) have been grouped together as the “contact” mapping systems. In this group it is 
essential to take electrical recordings from direct contact with the endocardial cavity or 
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the epicardial surface of the heart. The “noncontact” mapping 
system (the Ensite system) is a completely different method, 
whereby electrogram and myocardial activation sequence is 
obtained by measuring the voltage difference of depolarization 
without any contact with the endocardium. 
t r A D I t I O N A L  M A P P I N G
This technique is aimed to identify the activation sequence 
and the point of origin of the arrhythmia with reference to 
an electrode on the basis of circulating diagnostic catheters 
within the heart and recording endocardial electrical activity 
in different cardiac regions. It has been extensively used for 
diagnosis and treatment of most tachyarrhythmias for many 
years. Catheter placement for pacing, mapping and ablation 
are performed under fluoroscopy. During tachycardia, the 
process of detecting reentry circuits by performing cardiac pac-
ing in certain cardiac regions is known as “entrainment”, and 
it is one of the basic foundations of this technique along with 
electrically activated sequence detection.3 The disadvantages 
of this system, which is the mainstay of more advanced map-
ping systems used today, are the exposure to ionizing radiation 
because of the need for fluoroscopy-guidance; the inability to 
distinguish two-dimensional fluoroscopic images of anatomical 
regions; the difficulty in assessing the position of the catheter 
and the irretraceable characteristic of catheter-placed location; 
the small number of intracardiac electrograms obtained; and 
its inadequacy in the presence of complex arrhythmias, or 
multiple arrhythmias at a time, or short-lived and/or unstable 
arrhythmias.4
t H e  c A r t O  e L e c t r O A N A t O M I c A L 
M A P P I N G  s y s t e M
CARTO (Biosense-Webster Inc., California, United 
States), defined as an electromagnetical mapping system, de-
tects the precise locations of mapping and ablation catheters 
in three-dimensional environment by using the principles of 
electromagnetic field.5 Intracardiac electrograms are obtained 
from a large number of catheters in the cavities of the heart, 
as well as reference catheters. The system presents a three-
dimensional map of certain heart cavities and calculation of 
the differences between the duration of regional activation 
and reference activation could be used to obtain color-coded 
electrophysiological information.6 In a simpler way, the sys-
tem can be summarized as a magnetic emitter device which is 
placed on the table under the patient in supine position. This 
device is equipped with three spirals which create ultra-low 
magnetic field. The reference catheter is, on the other hand, 
a 7F directed catheter (NAVI-STAR) which has a magnetic 
sensor and a radiofrequency emitting thermocouple located 
on the tip. Three-dimensional placement of the catheter in the 
cavity of the heart is calculated by the processing program with 
the aid of information sent by the tip sensor, as it moves, about 
the distance from magnetic field sources. It accurately detects 
the magnetic field of the catheter, then sends the data of the 
location (x, y, and z axis) and orientation (yaw, pitch and roll 
movements).5 Thanks to the intracardiac electrograms from 
the points that the distal end of the catheter is in contact with, 
the localization on three-dimensional mapping is finalized 
through detection of activation duration and color coding. Red 
color-coded regions indicate the earliest activation; blue and 
purple latest activation; further, yellow and green indicates 
the intermediate activation. Although activation artifacts re-
sulting from rapid cardiac stimulation and movement during 
the tachyarrhythmia could be partially solved by placing the 
catheter on a relatively constant anatomical region, for chang-
ing the position of the patient or respiratory-related artifacts, 
an additional anatomical reference point has to be used. This 
reference could be obtained by placing a sensor carrying cath-
eter inserted into the coronary sinus or the right ventricular 
apex, or an outside patch (REF-STAR, QwikPATCH) could 
also be used. 
Electromagnetical system mapping of atrial flutter has in-
creased procedural success and reduced radiation exposure;7,8 
similarly, the system has led to increased rate of successful 
ablation in patients with atrial tachycardia.9-11 Especially in cases 
with atypical atrial flutter in congenital heart disease, despite 
atrial dilatation and complex anatomical structures, clear 
mapping of insulation barrier limiting tachyarrhythmia circuit 
has been reported to facilitate the isthmus block.12 Use of the 
system for ablation of accessory pathways and atrioventricular 
reentry has also shown success comparable to traditional meth-
ods.13,14 Case reports showing the successful use of the system 
for ventricular arrhythmia ablation are also available. Also, the 
system has been successfully used in idiopathic left ventricular 
tachycardia and right ventricular outflow tract tachycardia;15 it 
has also been an effective method in patients after surgery for 
congenital heart disease, and also for ventricular tachycardia 
ablation.16 In the treatment of arrhythmias originating from 
the left and right ventricle due to scar tissue, it was also found 
successful in creation of linear lesions.17 
Arrhythmogenic right ventricular dysplasia, whereby the 
right ventricular cardiac myocytes have been replaced by fibrotic 
tissue or fat, is a progressive disease. In these patients, in order 
to reduce the risk of sudden cardiac death, the implantable 
cardioverter-defibrillator should be used. However, as the 
progressive course of the disease may lead to an increase 
in the number of device shocks delivered to the patient, the 
ablation therapy might be considered later in the process. In 
these patients, there are studies in which the electroanatomic 
CARTO mapping of the myocardial tissue that is the focus 
of arrhythmias is employed; mapping and ablation therapy is 
applied in these patients in a similar manner to the one used 
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for ablating scar tissue-associated ventricular tachycardia in 
ischemic patients.18, 19 Boulos et al18 showed that the region 
mapped with CARTO is well-matched with both the magnetic 
resonance imaging (MRI) and with echocardiographic evidence 
showing the arrhythmogenic region. CARTO is also preferred 
to guide ablation treatment of atrial fibrillation with encircling 
lesions to isolate the pulmonary veins in the left atrium.20 As 
with other procedures, in these cases, CARTO diminishes 
fluoroscopy and shortens the procedure time. 
Despite these advantages, there are aspects of the system 
that need to be further developed:
 - The most important disadvantage relates to the need for 
sequential and point by point data acquiring during map-
ping; the arrhythmia circuit would be difficult to delineate 
in arrhythmias without continuity; this process may not be 
tolerated by the patient for a long time. However, thanks 
to mapping of low-voltage viable tissues and scar tissues, 
ablation can be done in sinus rhythm, thus avoiding use of 
techniques requiring induction of VT which may produce 
hemodynamic compromise.
 - Only one simultaneous rhythm mapping is possible. If an 
arrhythmia develops during sinus rhythm mapping, all map-
ping needs to be done all over again from the beginning.
 - Mapping takes time as it processes point by point. To solve 
this problem, the touch points were reduced with a later-
produced 26-electrode catheter and two magnetic-sensors 
Qwikstar. Moreover, with the Qwikmap system, the evalu-
ation of mapping can be done more quickly.
 - As mapping and ablation is carried out with a special 
catheter, it confers additional costs; thus, the total cost of 
the procedure is increased. Also, bidirectional movement 
of the catheter is restricted. 
 - The system does not detect catheters without magnetic 
sensors.
 - Since the mapping evaluates only one cardiac cavity, the site 
of early activation may not necessarily be the origin of the 
arrhythmia; however, tachycardia may originate in another 
cavity which is not included in the mapping. On the other 
hand, this problem exists in other mapping systems as well. 
Recent technological advances gave way to inclusion of 
three-dimensional computed tomography (CT) and MRI 
images into the standard system of the CARTO electroana-
tomic mapping (CARTOSYNC). One step further to this, by 
combining these images with the CARTO maps, more precise 
anatomic CARTO maps can be created (CARTOMERgE). 
It is also possible to include data from intracardiac echocar-
diography (CARTOSOUND). 
To summarize, CARTO has been tested in all heart cavi-
ties and for a variety of arrhythmias. CARTO is a system that 
reduces the need for fluoroscopy, and needs to continue to be 
developed due to its disadvantages mentioned above. 
M A P P I N G  w I t H  M U L t I - e L e c t r O D e 
b A s K e t  c A t H e t e r
Placing the helical structure catheter which consists of 
basket-shaped electrodes in the heart cavity, electrograms 
are recorded from different locations. The collapsed catheter 
is introduced within a long sheath. Upon entering a cavity, 
the sheath is pulled back and the catheter assumes its spiral 
form. The most commonly used one is the 64-electrode basket 
catheter (Boston Scientific, California, USA). The number 
of studies using this method in the literature are limited. It 
has an advantage especially in short-lasting arrhythmias and 
multi focal tachycardia, as many simultaneous recordings are 
gathered from the given cardiac cavity.21 Recording just a few 
beats might be enough to uncover the arrhythmia circuit. In 
the atrial flutter ablation, it is valuable in determining the 
isthmus point and slow conduction point.22,23
The limitations of the system are as follows:
 - Myocardial contact of the basket catheter within the cavity 
might not be proper because it may be smaller or bigger for 
the cavity; and therefore it may not stay stable. Recording 
and evaluation of electrograms can be difficult. 
 - As the basket catheter is multi-electrode and therefore 
requires a multi-channel recording device, such devices 
should be available in the laboratory. 
 - Use of ablation and diagnostic catheters along with basket 
catheter in the same cardiac chamber might be difficult.
 - The number of studies with human participants is quite low.
 - It is difficult to use the basket catheter in structures such 
as the left atrial appendage, or the pulmonary veins.
 - Electrode contact may be affected by cardiac contractions; 
as a result, the recordings can be misleading.
N O N c O N t A c t  M A P P I N G
The noncontact multi-electrode mapping system, EnSite 
3000 (St. Jude, Minnesota, USA), uses electrograms obtained 
without direct contact with the endocardium. The system is 
composed of a 64-electrode 9F multi-electrode array (MEA) 
catheter mounted on a 7.5 ml balloon; the system also com-
prises the reference patch electrode, amplifiers and processor 
unit. MEA catheter filters and records intracavitary far-field 
potentials at a frequency of 1.2 kHz. Up to 3360 virtual unipo-
lar electrograms are obtained simultaneously from the cavity 
surrounding the cardiac catheter and thus a three-dimensional 
map of the cavity can be constructed.24,-26 The MEA catheter 
balloon is advanced into the heart cavity within a special sheath 
and inflated 50/50 percent with isotonic/contrast material. 
Then, mapping is completed with the construction of a three-
dimensional map, and conventional ablation and diagnostic 
catheters can be used around the balloon. The MEA catheter 
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determines the location catheters around by spreading low 
frequency signal of 5.68 kHz. The catheter’s sensitivity of de-
termining location of surrounding catheters in 35 mm range 
is quite high, however sensitivity decreases with distance of 
40 mm and above.27-29 By scanning the cavity, the system gets 
1200 measurement data per second from 3360 electrograms. 
Therefore, the whole activation map of the cavity could be 
constructed with a single beat. Thanks to this feature, it could 
be preferred in arrhythmias associated with hemodynamic 
compromise, short-lasting arrhythmias or in arrhythmias which 
are hard to re-induce. As it maps the whole cavity, it could 
provide invaluable data in situations with more than one ar-
rhythmia, or situations with more than one arrhythmogenic 
foci and reentry circuits. 
EnSite had been tried in ischemic VT ablation, and has 
been proven useful and successful at all stages from detection 
of arrhythmogenic foci to guiding ablation.30 When the MEA 
catheter is inserted into the left atrium, it can successfully 
detect arrhythmogenic foci outside the pulmonary veins.31 
In a study,32 it was used in complicated anatomical and post-
operative substrates; noncontact mapping was conducted for 
11 arrhythmias in 6 patients after Fontan procedure, and linear 
lesions were produced. However, high recurrence rates draw 
some attention. In another study it was used to treat atypical 
right atrial flutter;33 it was observed that during the 17-month 
follow-up period, in 13 of 15 patients, arrhythmia was com-
pletely eliminated.
Weak points of the system are:
 - MEA catheter balloon might make manipulation of the 
other catheters difficult especially in the atria.34
 - As the sensitivity of the MEA catheter is less than 40 mm 
from the center, when used in dilated hearth cavities, the 
catheter needs to be repositioned.26
 - Potentials taken from remote regions are low-amplitude, 
and therefore they might be confused with scar tissue.
 - Due to use of high-profile balloon, anticoagulation is 
needed, and this can lead to bleeding complications.
 - As in CARTO, this system maps only one cavity and earli-
est activation does not necessarily mean the origin of ar-
rhythmia. It should always be remembered that arrhythmia 
might originate in another cavity. 
L O c A L I s A
The LocaLisa system (Medtronic, Minneapolis, USA) 
is a three-dimensional mapping system that allows place-
ment of conventional catheters to the heart chambers under 
fluoroscopic guidance. Catheters are located and placed with 
the aid of three electric fields (x, y and z planes) produced by 
administering 30 kHz frequency and 1 mA current from three 
adhesive skin patch electrodes in orthogonal position. Electrical 
current applied on thorax passes through the internal organs, 
causing voltage drop, which is recorded by the electrodes.35 
Thus, the position and the distance of catheters to each other 
can be calculated. The frequency of the current emitted from 
the electrodes does not interfere with electrograms; also 1 mA 
current is harmless to the patient and in accordance with the 
international safety standards. Placement of the electrodes 
is as follows; the first electrode is placed on the heart, the 
second one is placed laterally, the third and the last one are 
placed posterior to the heart. The posterior electrode is also 
used as the current collector electrode during radiofrequency 
ablation. The system has been reported to locate catheters 
with 2 mm precision.36
It has been shown that the system can be used for ablation of 
supraventricular tachycardias and reduces exposure to ionizing 
radiation by 35%.37 In a different study, it was compared with the 
traditional method in the ablation of atrial flutter.38 It was also 
documented that mean fluoroscopy time was decreased from 16 
minutes to 7 minutes. Particularly, in 9 out of 26 patients total 
fluoroscopy time throughout the entire procedure took less 
than 1 minute. This system was also used for the treatment of 
pulmonary vein isolation for atrial fibrillation, and there were 
meaningful decreases in radiofrequency application time, total 
procedure time, and fluoroscopy time.39,40,41
The limitations of the system which needs a special catheter 
are as follows: 
 - Artifact formation due to respiration and contractions 
makes mapping difficult.
 - Patching electrodes to areas in close proximity of the sur-
face electrocardiogram electrodes may cause interference.
 - As all cardiac formations are not homogenous, all voltage 
drops in electric field may not be reliable.
e N s I t e  N A v X
EnSiteNavX (St. Jude, Minnesota, ABD), which was based 
on LocaLisa technology, was developed and integrated with 
the EnSite system. Just like LocaLisa, it uses three electrode 
patches to form 3 orthogonal planes (x, y, z); 5 kHz frequency 
signals emitted from the electrodes form a voltage gradient 
between electrode pairs of the electrode. Voltage gradients 
from each of the three planes is calculated and combined, and 
then three-dimensional position of the catheters is determined. 
Positions of 64 electrodes and 12 conventional catheters are 
simultaneously determined up to 90 times per second. Map-
ping of the current heart chamber could be constructed by 
circulating one of the catheters in the endocardial cavity.42 
With help of the information of electrode length and the dis-
tance between electrodes, contact location and electrode tip 
could be modeled and the distance could be calculated from 
the geometric model. Thanks to the filters, mapping can be 
continued during ablation. In addition, CT and MR images can 
be uploaded to the system (NavX Fusion), and automatically 
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combined with the voltage map.43 After geometric modeling, 
voltage map and regional activation map can be constructed 
with point by point consecutive catheter touch. Extracardiac 
signals are used as fixed reference. Then, the program merges 
activation map with the geometric model. 
There are studies on the use of the EnsiteNavX system 
in the treatment of atrial fibrillation. An Italian registry, 
which was recently published,44 revealed that in patients who 
underwent catheter ablation for atrial fibrillation (AF) with 
the NavX mapping system, one and two year freedom from 
AF recurrence were 67.4% and 50.0%, respectively. A former 
study showed similar results for circumferential pulmonary vein 
isolation done with either Ensite/NavX or Carto mapping.45 
In another study, AF ablation procedures which were done 
with the NavX system ware compared with the CartoMerge 
system.46 Pulmonary vein isolation, linear ablation or both were 
used in this trial. There was no significant difference between 
total procedure time and clinical outcomes.
The NavX mapping system is more reliable than its pre-
decessor LocaLisa and other systems in terms of respiratory 
artifacts. As in LocaLisa a fixed electrode in the heart (for 
example, settled into the coronary sinus) could be used as 
well as a special algorithm that can be useful in reducing the 
system artifact. In addition to this, an important advantage of 
the system is that it does not need a special catheter. Another 
important point is its ability to localize esophagus directly. 
Its current limitations include:
 - Patient-specific anatomical deformities and scar tissues can 
be deceptive if filters settings are not adjusted.
 - It might be difficult to view the desired endocardial region 
with catheter tip. With anatomical focus “oversizing”, ori-
entation to the region can be more comfortable with the 
tip of the catheter. Table 1 presents a comparison among 
the mapping systems which are in general use.
c O N c L U s I O N
As technology advances, industry comes up with newer 
devices, newer programs and newer mapping systems. Initial 
strategies, like the basket catheter, ceased to exist in relatively 
short time periods. As the electrophysiology community de-
mands better technology to identify the arrhythmia focus more 
clearly, to be exposed to lower radiation, and to radically treat 
electrical disease, the industry has responded with various 
technological advances by developing quite versatile electro-
anatomical mapping systems. These mapping systems facilitate 
the electrophysiologist’s and ablationist’s work, and render it 
possible to treat more complicated cases, like atrial fibrillation 
and ventricular tachycardia. Importantly, the available systems 
provide the operator with more options in deciding on the use 
of the most suitable system for the patient’s particular type of 
tachycardia and arrhythmogenic substrate, which plays a major 
role in the pursuit of success.
tAbLe 1. Comparison of general Characteristics of Electroanatomical Mapping Systems in general Use.
Parameter cArtO ensite NavX ensite Array
Simultaneous multiple chamber rendering + + -
Transparent view - + +
Activation time mapping + + +
Voltage mapping + + +
Nonsustained tachycardia mapping Hardly Hardly Best
Hemodynamically unstable tachycardia mapping Not recommended Not recommended Best
Catheter tip-tissue contact visualization ++ + +
Ablation catheter use Specific catheter Any Any
Spatial accuracy (mm) 1 <1 <1
Temporal accuracy (frame) 0.1 K 1.2 K 1.2 K
Multiple catheter use Detects only magnetic 
sensor catheters
Possible Possible
Scar tissue mapping +++ + +
Catheter manipulation + + Array catheter limits ablation 
catheter manipulation if cardiac 
cavity is not dilated
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